Subcutaneous panniculitis-like T-cell lymphoma

Active Research Protocols

  1. 09-C-0065 – Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in T and NK-Cell Lymphomas
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014